EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis

Immune recognition of citrullinated epitopes

(2016) Hai Nguyen et al.   IMMUNOLOGY

Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein

(2016) S. Anwar Jagessar et al.   JOURNAL OF IMMUNOLOGY

B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses

(2016) Sara J. Ireland et al.   JOURNAL OF NEUROIMMUNOLOGY

Increased ex vivo antigen presentation profile of B cells in multiple sclerosis

(2016) Amandine Mathias et al.   Multiple Sclerosis Journal

EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model

(2016) Bert A. ‘tHart et al.   TRENDS IN MOLECULAR MEDICINE

Increased ex vivo antigen presentation profile of B cells in multiple sclerosis

(2016) Amandine Mathias et al.   Multiple Sclerosis Journal

Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets

(2015) H.-Christian von Büdingen et al.   EUROPEAN NEUROLOGY

Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation

(2015) Giorgio Camilli et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The Role of Latently Infected B Cells in CNS Autoimmunity

(2015) Ana Citlali Márquez et al.   Frontiers in Immunology

Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis

(2014) Claire M. Bradford et al.   JOURNAL OF NEUROIMMUNOLOGY

Pathways of Antigen Processing

(2013) Janice S. Blum et al.   Annual Review of Immunology

Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane

(2013) R. Goold et al.   JOURNAL OF CELL SCIENCE

The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model

(2013) S. Anwar Jagessar et al.   Journal of Neuroimmune Pharmacology

Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34–56 Peptide

(2013) Krista G. Haanstra et al.   PLoS One

B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model

(2012) S. Anwar Jagessar et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56peptide in incomplete adjuvant

(2011) S. Anwar Jagessar et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Presentation of Soluble Antigens to CD8+ T Cells by CpG Oligodeoxynucleotide-Primed Human Naive B Cells

(2011) W. Jiang et al.   JOURNAL OF IMMUNOLOGY

Resident B cells regulate thymic expression of myelin oligodendrocyte glycoprotein

(2011) Eitan M. Akirav et al.   JOURNAL OF NEUROIMMUNOLOGY

Contribution of Myelin Autoantigen Citrullination to T Cell Autoaggression in the Central Nervous System

(2010) A. Carrillo-Vico et al.   JOURNAL OF IMMUNOLOGY

How Immune Peptidases Change Specificity: Cathepsin G Gained Tryptic Function but Lost Efficiency during Primate Evolution

(2010) W. W. Raymond et al.   JOURNAL OF IMMUNOLOGY

Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

(2010) Alberto Ascherio et al.   Journal of Neuroimmune Pharmacology

Comparison of human B cell activation by TLR7 and TLR9 agonists

(2008) John A Hanten et al.   BMC IMMUNOLOGY

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients

(2008) F G Joseph et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Autoimmunity Against Myelin Oligodendrocyte Glycoprotein Is Dispensable for the Initiation Although Essential for the Progression of Chronic Encephalomyelitis in Common Marmosets

(2008) S. Anwar Jagessar et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE